Upcoming Events

We will update this section with upcoming events

---

recent News

CDC Antibiotic Awareness Week: Nov 18-24, 2024 
ADSP celebrated CDC Antibiotic Awareness Week! 
​The purpose of this week is to increase awareness of antibiotic resistance and the importance of careful antibiotic use. Antibiotics can save lives, but any time antibiotics are used, they can cause side effects and contribute to the development of antimicrobial resistance. See the infographic to the right for more impacts of antibiotic resistance.

Always Remember:
Prescribe the right antibiotic, at the right dose, for the right duration, and at the right time.

• Reassess therapy to stop or tailor treatment based on the patient clinical condition and diagnostic test results.
• Use of the shortest effective duration of antibiotic therapy is a key antibiotic stewardship strategy.

​Answers to the Antibiotic Awareness Week
​word search here!

Answers to the Antimicrobial Emoji Quiz here!

---

​​Congratulations to the winners of the 3rd Annual ADSP Bug Bowl (2023):
​Team Notorious MIC! Kathy Ritter, MD, Emmy Wanjiku, MD, and Alli Cowett, PharmD!

Previous Bug Bowl Teams from 2022 and 2023

​​


​ADSP Team Members Complete 2nd Year of the 50 Mile Relay Run
​​
In October, "The Stewards", a five-member team completed 50 miles of relay running.

​All regions of NM system were represented. From left to right, Jaime Borkowski (Delnor), Erin Weslander (NMH), Mike Postelnick (System ADSP Director), Aaron Oliver (Palos), and Michael Dickens (NMH/Huntley) are pictured after completing the race! 

ADSP Antimicrobial Resistance Fighter Award
​
​Clinicians are awarded this honor for excellence in Antimicrobial Stewardship. It takes all members of the healthcare team to provide optimal infection treatment and combat the development and spread of microbial resistance. 

April 2025 winner:
Randie Landini, PharmD earned the ​Blue Belt Award in Antimicrobial Resistance Fighting

​​
Fill out this form to nominate yourself of a colleague for this distinct award!

​See the past winner page for more stewardship excellence at Northwestern Medicine.

​

​​
ADSP Team Member, Justin Moore, presents Emory Transplant Grand Rounds

Dr. Justin Moore, our very own COVID-19 transplant pharmacist expert, was invited to discuss COVID-19 infection in these difficult to treat and at-risk patients.

​
​

​IDWeek 2022

​Check out the IDWeek interview with our CDH Antimicrobial and Diagnostic ​Stewardship Pharmacist at Northwestern Medicine Central DuPage Hospital, Dr. Radhika Polisetty. She discusses efforts to decrease hospital-acquired C. difficile infections. 

---

​NM ADSP RECENT PUBLICATIONS

• Wu E, Osborn RL, Bertram CM, Moore WJ, Galvin SR, Bolon MK, Masters MC, Krueger KM. Tecovirimat Use in Ambulatory and Hospitalized Patients with Monkeypox Virus Infection. Sexually Transmitted Diseases. 2023; 50(3): 172-174.

• Larry RC, Hoff BM, Bertram CM. Evaluation of Microbiological Concordance of a Rapid Molecular Diagnostic Pneumonia Panel in a Real-World Population with Pneumonia. The Journal of Applied Laboratory Medicine. 2023: jfac133

​​

• Patel D, Ng T, Madani LS, Persell SD, Greg M, Roemer PE, Oberoi SK, and Linder JA. Antibiotic stewardship to reduce inappropriate antibiotic prescribing in integrated academic health-system urgent care clinic. Infection Control & Hospital Epidemiology. 2022: 1-10.

​

• Scheetz MH, Chang J, Baretto EF, et al. Nephrotoxin Stewardship Alongside Antimicrobial Stewardship. Clinical Infectious Diseases. 2022.

 

• Weslander E, Thomas H, Jeune R, et al. Cefadroxil Use for Musculoskeletal Infections in an Academic Pediatric Hospital. Journal of the Pediatric Infectious Diseases Society. 2022: 590-593.

​

• Venugopalan V, Casaus D, Kainz L, Slaton, CN, Hurst N, Bruzzone M, Hu C, Sword G, Cherabuddi K, Iovine N, Liu J, Scheetz MH, Rhodes N, Maranchick N, Peloquin CA, Klinker K, Alshaer MH. Use of therapeutic drug monitoring to characterize cefepime-related neurotoxicity. Pharmacotherapy. 2022; 00: 1- 9.

​

• Boesch TS, Eischen E, Ries AM, Quinn A, et al. Promoting Beta-lactam utilization through suppression of electronic medical record cross-allergy alters. American Journal of Health-System Pharmacy. 79 (S2) 2022.

• Rohani R, Scheetz MH, et al... Rhodes NJ. Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia. Journal of Antimicrobial Chemotherapy. 77 (11) 2022.

follow us on twitter

Tweets by NM_IDSteward